Enhanced cytostatic activity of statins in mouse mammary carcinoma cells overexpressing β2-chimaerin

Molecular Medicine Reports

Volumn 2, Issue 1, 2009, Pages 97-102

  Menna, Pablo Lorenzano ^a   Parera, Romina L ^a,b   Cardama, Georgina A ^a   Alonso, Daniel F ^a   Gomez, Daniel E ^a   Farina, Hernan G ^a  

^a UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

^b National Institute of Medicaments (INAME)   (Argentina)

Author keywords

Breast cancer; Lovastatin; Rac; Rho GTPases; Simvastatin; Treatment

Indexed keywords

ATORVASTATIN; AZATHIOPRINE; CHIMERIN; CHIMERIN BETA 2; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MERCAPTOPURINE RIBOSIDE; MEVINOLIN; PRAVASTATIN; RAC PROTEIN; ROSUVASTATIN; SIMVASTATIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER CHEMOTHERAPY; CANCER INHIBITION; CARCINOMA CELL; CELL LEVEL; CONTROLLED STUDY; CYTOSTASIS; DRUG EXPOSURE; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME INACTIVATION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN DOMAIN;

EID: 69249135482     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr-00000068     Document Type: Article

References (30)

1. Ellenbroek SI and Collard JG: Rho GTPases: functions and association with cancer. Clin Exp Metastasis 24: 657-672, 2007.
2. Buchsbaum RJ: Rho activation at a glance. J Cell Sci 120: 1149-1152, 2007.
3. Rossman KL, Der CJ and Sondek J: GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6: 167-180, 2005. (Pubitemid 40215811)
4. Bustelo XR, Sauzeau V and Berenjeno IM: GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 29: 356-370, 2007. (Pubitemid 46597867)
5. Kazanietz MG: Eyes wide shut: protein kinase C isozymes are not the only receptors for the phorbol ester tumor promoters. Mol Carcinog 28: 5-11, 2000.
6. Yang C and Kazanietz MG: Chimaerins: GAPs that bridge diacyl-glycerol signalling and the small G-protein Rac. Biochem J 1: 1-12, 2007. (Pubitemid 46569861)
7. Menna PL, Skilton G, Leskow FC, Alonso DF, Gomez DE and Kazanietz MG: Inhibition of aggressiveness of metastatic mouse mammary carcinoma cells by the beta2-chimaerin GAP domain. Cancer Res 63: 2284-2291, 2003. (Pubitemid 36538638)
8. Konstantinopoulos PA, Karamouzis MV and Papavassiliou AG: Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat Rev Drug Discov 6: 541-555, 2007.
9. Wong WW, Dimitroulakos J, Minden MD and Penn LZ: HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis. Leukemia 16: 508-519, 2002. (Pubitemid 34460459)
10. Rao S, Porter DC, Chen X, Herliczek T, Lowe M and Keyomarsi K: Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Natl Acad Sci USA 96: 7797-7802, 1999. (Pubitemid 29328361)
11. Farina HG, Bublik DR, Alonso DF and Gomez DE: Lovastatin alters cytoskeleton organization and inhibits experimental metastasis of mammary carcinoma cells. Clin Exp Metastasis 19: 551-559, 2002.
12. Alonso DF, Farias EF, Urtreger A, Ladeda V, Vidal MC and Bal de Kier Joffe E: Characterization of F3II, a mammary sarcomatoid carcinoma cell line originated from a mouse adenocarcinoma. J Surg Oncol 62: 288-297, 1996. (Pubitemid 26262354)
13. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM and Strober W: Current protocols in immunology. In: Related Isolation Procedures and Functional Assays. Vol 1. Coico R (ed). John Wiley & Sons Inc., New York, NY, 1995.
14. Alonso DF, Farina HG, Skilton G, Gabri MR, De Lorenzo MS and Gomez DE: Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis. Breast Cancer Res Treat 50: 83-93, 1998. (Pubitemid 28438864)
15. + T lymphocytes. J Clin Invest 111: 1133-1145, 2003.
16. Jaffe AB and Hall A: Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21: 247-269, 2005.
17. Tang Y, Olufemi L, Wang MT and Nie D: Role of Rho GTPases in breast cancer. Front Biosci 1: 759-776, 2008. (Pubitemid 351599780)
18. Sahai E and Marshall CJ: RHO-GTPases and cancer. Nat Rev Cancer 2: 133-142, 2002.
19. Zohn IE, Symons M, Chrzanowska-Wodnicka M, Westwick JK and Der CJ: Mas oncogene signaling and transformation require the small GTP-binding protein Rac. Mol Cell Biol 18: 1225-1235, 1998. (Pubitemid 28100886)
20. Malliri A, van der Kammen RA, Clark K, van der Valk M, Michiels F and Collard JG: Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 417: 867-871, 2002. (Pubitemid 34670335)
21. Mira JP, Benard V, Groffen J, Sanders LC and Knaus UG: Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway. Proc Natl Acad Sci USA 47: 185-189, 2000. (Pubitemid 30055805)
22. Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H, Harbeck N, Schmitt M and Lengyel E: Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19: 3013-3020, 2000. (Pubitemid 30389092)
23. Istvan E: Statin inhibition of HMG-CoA reductase: a 3-dimensional view. Atheroscler Suppl 4: 3-8, 2003.
24. Neuvogen PJ, Backman JT and Niemi M: Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and ravastatin. Clin Pharmacokinet 47: 463-474, 2008.
25. Thelen KM, Rentsch KM, Gutteck U, Heverin M, Olin M, Andersson U, von Eckardstein A, Björkhem I and Lütjohann D: Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin. J Pharmacol Exp Ther 316: 1146-1152, 2006. (Pubitemid 43345288)
26. Olson MF, Ashwort A and Hall A: An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269: 1270-1272, 1995.
27. Coleman M and Olson MF: Rho GTPase signalling pathways in the morphological changes associated with apoptosis. Cell Death Differ 9: 493-504, 2002. (Pubitemid 34521177)
28. Coniglio SJ, Jou TS and Symons M: Rac1 protects epithelial cells against anoikis. J Biol Chem 276: 28113-28120, 2001. (Pubitemid 37391512)
29. Costello PS, Cleverley SC, Galandrini R, Henning SW and Cantrell DA: The GTPase rho controls a p53-dependent survival checkpoint during thymopoiesis. J Exp Med 192: 77-85, 2000. (Pubitemid 30470808)
30. Poppe D, Tiede I, Fritz G, Becker C, Bartsch B, Wirtz S, Strand D, Tanaka S, Galle PR, Bustelo XR and Neurath MF: Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins. J Immunol 176: 640-651, 2006. (Pubitemid 43023313)